AI assistant
LITTLE GREEN PHARMA LTD — AGM Information 2021
Sep 5, 2021
65232_rns_2021-09-05_1dcb3469-8a1e-4fda-a046-b631bbe5062b.pdf
AGM Information
Open in viewerOpens in your device viewer
6 SEPTEMBER 2021
AGM DATE AND CLOSING DATE FOR DIRECTOR NOMINATIONS
ASX ANNOUNCEMENT
Little Green Pharma Ltd ( ASX: LGP , “ LGP ” or the “ Company ”) advises that in accordance with ASX Listing Rule 3.13.1 its Annual General Meeting (“ AGM ”) will be held at 2pm (AWST) on Friday, 5 November 2021.
The AGM will be held at Suite 2, Level 2, 66 Kings Park Road, West Perth, 6005, Western Australia.
An item of business at the AGM will be the re-election and appointment of directors. In accordance with the Company’s Constitution, the closing date for receipt of nominations from persons wishing to be considered for election as a director is 35 business days prior to the meeting, being Thursday, 16 September 2021.
Any nominations must be received at the Company’s registered office no later than 5:00pm (Perth time) on Thursday, 16 September 2021.
==> picture [155 x 201] intentionally omitted <==
BY ORDER OF THE BOARD
____________ Alistair Warren Company Secretary
ENDS
Head Office PO Box 690, West Perth WA 6872 | T + 61 8 6280 0050 | E [email protected] | littlegreenpharma.com
==> picture [56 x 46] intentionally omitted <==
For further information please contact:
Alistair Warren Fleta Solomon Company Secretary Managing Director Little Green Pharma Little Green Pharma E : [email protected] E : [email protected] T : +61 8 6280 0050 T : +61 8 6280 0050
About Little Green Pharma
==> picture [184 x 206] intentionally omitted <==
Little Green Pharma is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.
The Company has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, being a 21,500m2 cultivation and 4,000m2 GMP manufacturing facility capable of producing 20 tonnes of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing ~3 tonnes of medicinal cannabis biomass per annum.
Little Green Pharma products comply with all required Danish Medicines Agency and Therapeutic Goods Administration regulations and testing requirements. With a growing range of products containing differing ratios of active ingredients, Little Green Pharma supplies medical-grade cannabis products to Australian, European and overseas markets.
The Company has a strong focus on patient access in the emerging global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop innovative new delivery systems.
For more information about Little Green Pharma go to: www.littlegreenpharma.com
Help us be Green
LGP investors are encouraged to go paperless and receive Company communications, notices and reports by email. This will ensure efficient communication during COVID-19 while also helping to reduce our costs and environmental footprint.
To easily update your communication preferences, visit: www.computershare.com.au/easyupdate/lgp
Head Office PO Box 690, West Perth WA 6872 | T + 61 8 6280 0050 | E [email protected] | littlegreenpharma.com